First Patient Enrolled in Phase 2 Clinical Trial of Elafibranor for Bile Duct Disease
GENFIT has enrolled the first patient in a Phase 2a clinical trial of elafibranor as a treatment for a liver bile duct disease known as primary…
Cholangitis
New ‘Liver Line’ Online Community to Share Updates on Health, Research, Treatments
A new online community, called Liver Line and sponsored by Galectin Therapeutics, offers the latest information on liver health and research into liver diseases. On Liver…
Enanta’s EDP-305 Therapy Shows Promise in Treating Non-Alcoholic Fatty Liver Disease
Candidate drug EDP-305 reduced fibrosis progression and improved non-alcoholic fatty liver disease (NAFLD) and primary biliary cholangitis (PBC) disease settings in several preclinical animal models, says…
Recent Posts
- Better to have Kasai surgery before liver transplant for biliary atresia
- All spots filled in trial testing Vir’s combo treatment for hepatitis D
- Most recent liver stiffness test best predicts risk of PBC progression
- Novel gene mutation is likely cause of newborn’s rare liver disease
- Quitting drinking was the best decision I ever made